KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Cash (2016 - 2025)

Historic Change in Cash for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $64.0 million.

  • Colgate Palmolive's Change in Cash fell 4838.71% to $64.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year decrease of 8409.89%. This contributed to the annual value of $130.0 million for FY2024, which is 3193.72% down from last year.
  • Latest data reveals that Colgate Palmolive reported Change in Cash of $64.0 million as of Q3 2025, which was down 4838.71% from $103.0 million recorded in Q2 2025.
  • Colgate Palmolive's 5-year Change in Cash high stood at $132.0 million for Q3 2023, and its period low was -$163.0 million during Q4 2022.
  • Its 5-year average for Change in Cash is $20.6 million, with a median of $31.0 million in 2024.
  • In the last 5 years, Colgate Palmolive's Change in Cash skyrocketed by 46896.55% in 2021 and then tumbled by 102000.0% in 2024.
  • Over the past 5 years, Colgate Palmolive's Change in Cash (Quarter) stood at -$126.0 million in 2021, then decreased by 29.37% to -$163.0 million in 2022, then skyrocketed by 109.2% to $15.0 million in 2023, then tumbled by 1020.0% to -$138.0 million in 2024, then surged by 146.38% to $64.0 million in 2025.
  • Its Change in Cash stands at $64.0 million for Q3 2025, versus $103.0 million for Q2 2025 and $16.0 million for Q1 2025.